Article
Presenilin 1 gene silencing by <i>S</i> ‐adenosylmethionine: a treatment for Alzheimer disease?
2 Apr 2003
Abstract excerpt
Presenilin 1 (PS1) is a key factor for beta-amyloid (Ab) formation in Alzheimer disease (AD). Homocysteine accumulation, frequently observed in AD patients, may be a sign of a metabolic alteration in the S-adenosylmethionine (SAM) cycle, which generates the overexpression of genes controlled by methylation of their promoters, when the cytosine in CpG moieties becomes unmethylated. The methylation of a gene...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
